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These tables present the results of the September 1965 survey of 
the immunization status of the population of the United States, conducted 
by the Bureau of the Census in cooperation with the Communicable Disease 
Center. Information is presented on poliovaccine status, both oral and 
inactivated, for ages under 20 years; diphtheria-pertussis-tetanus immu­
nization for children under 10 years; measles vaccine history and measles 
history for children through 10 years of age.
Tables of data are presented in the following Sections:
Section A. Tables 1-5. Summary Tables, Poliovaccine Immunization 
Status, Ages Under 20 Years
Section B. Tables 6-10. Diphtheria-Pertussis-Tetanus Immunization 
Status, Ages 1-9 Years
Section C. Table 11. Immunization Status, Infants Under 1 Year
Section D. Tables 12-13. Measles History and Measles Vaccine History, 
Ages Through 10 Years
Section E. Tables 14-15. Standard Error Tables, Computed by the Bureau 
of the Census.
NOTE: Estimates for each age group in each table have been independently
rounded without adjustment to the table total. This accounts for 




Section A. Summary Tables, Poliovaccine Immunization Status
Ages Under 20 Years
Table 1A. Poliovaccine Status - United States, 1965. Ages Under 20 Years
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OPV)
Percent of Population with Doses as Specified
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 




1-4 24.3 25 .3 24.3 73.9 16.3 9.9
5-9 47.3 28.3 14.4 89 .9 7.1 3.0
10-14 49 .5 29 .2 13.4 92.1 5.8 2.1
15-19 43 .9 31.5 13 .0 88.3 7.9 3.7
*Also includes persons with unknown immunization status and unknown number of doses.
Table IB, Poliovaccine Status - United States, 1965, Ages Under 20 Years 
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OPV) 
Number of Persons in the Population (thousands)
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 




1-4 4 006 4 176 4 003 12 185 2 682 1 631
5-9 9 627 5 754 2 930 18 311 1 445 604
10-14 9 445 5 578 2 567 17 590 1 111 398
15-19 7 305 5 249 2 158 14 712 1 319 624
*Also includes persons with unknown immunization status and unknown number of doses.
Table 2A. Poliovaccine Status - United States, 1965. Ages Under 20 Years - White
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OPV)
Percent with Doses as Specified
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 




1-4 25.2 26.9 24.4 76.6 15.0 8.5
5-9 48.3 29.3 13 .8 91.4 5.9 2.7
10-14 50.2 30.4 12.5 93.1 4.9 2.0
15-19 44.4 32.7 12.2 89.2 7.1 3.7
*Also includes persons with unknown immunization status and unknown number of doses.
Table 2B. Poliovaccine Status - United States, 1965. Ages Under 20 Years - White 
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OPV)
Number of Persons (thousands)
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 




1-4 3 495 3 737 3 389 10 621 2 078 1 173
5-9 8 400 5 092 2 407 15 899 1 035 463
10-14 8 240 4 998 2 052 15 290 812 321
15-19 6 468 4 757 1 774 12 999 1 034 535
*Also includes persons with unknown immunization status and unknown number of doses.
Table 3A. Poliovaccine Status - United States, 1965. Ages Under 20 Years - Nonwhite
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OFV)
Percent with Doses as Specified
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 




1-4 19 .4 16.7 23.4 59.6 23 .0 17 .5
5-9 41.4 22.3 17.6 81.3 13 .9 4.8
10-14 45.0 21.6 19.3 85 .9 11.2 2.9
15-19 40.1 23.6 18.4 82.1 13.6 4.3
*Also includes persons with unknown immunization status and unknown number of doses.
Table 3B. Poliovaccine Status - United States, 1965. Ages Under 20 Years - Nonwhite 
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OPV)
Number of Persons (thousands)
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 




1-4 510 440 615 1 565 604 459
5-9 1 228 660 522 2 410 413 141
10-14 1 205 579 516 2 300 301 77
15-19 83 6 491 383 1 710 284 89
*Also includes persons with unknown immunization status and unknown number of doses.
Table 4. Poliovaccine Status - United States, 1965. Ages Under 20 Years 
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OFV) 
Percent with Doses as Specified 
Standard Metropolitan Statistical Areas
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV








1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 
0 OPV +1.2 IPV
Central Cities - Total
1-4 23 .0 26.6 22.2 71.8 18.3 9 .9
5-9 43.9 30.7 14.3 88.9 8.4 2.7
10-14 46.9 31.2 13.3 91.3 7.0 1.6
15-19 37 .9 34.2 13.9 86.0 10.1 3.9
Central Cities - White
1-4 24.5 29.6 22.6 76.7 15.4 7.9
5-9 44.9 32.0 14.0 90.9 6.8 2.4
10-14 48.1 32.8 11.9 92.8 6.0 1.2
15-19 38.8 36.4 13.0 88.2 8.5 3.3
Central Cities - Non*»rhite
1-4 19.4 19 .0 21.1 59.4 25.8 14.8
5-9 41.2 27.1 15.3 83.5 13 .0 3.5
10-14 43.2 26.4 17.2 86.9 10.1 3.0
15-19 34.5 26.2 17.4 78.1 15.9 5.9
Remaining Population in £MS.Areas
1-4 25.2 26.6 26.1 77.9 15.6 6.5
5-9 48.4 30.0 14.0 92.3 5.8 1.9
10-14 49.7 31.5 12.2 93.3 5.0 1.7
15-19 45.6 32.7 11.8 90.1 7.1 2.8
Populat ion Outside SMS Areas
1-4 24.3 23.0 24.0 71.4 15.3 13.3
5-9 48.7 24.7 14.8 88.3 7.4 4.3
10-14 51.1 25.5 14.8 91.5 5.7 2.8
15-19 46.8 28.3 13.3 88.5 7.0 4.5
*Also includes persons with unknown immunization status and unknown number of doses.
Table 5. Poliovaccine Status - United States, 1965. Ages Under 20 Years 
Inactivated Poliovaccine (IPV) and Oral Poliovaccine (OPV) 
Percent with Doses as Specified 
Geographic Divisions
Age
3 or more IPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 





1-4 27 .3 21.8 27 .5 76.6 16.5 6.8
5-9 57.9 19.6 14.5 92.0 5.7 2.3
10-14 58.3 19.9 14.8 93.0 5.2 1 .8
15-19 47 .4 30.0 9.8 87.2 9.0 3 .8
Middle Atlantic
1-4 29 .3 30 .9 20.4 80.6 12.9 6.5
5-9 50.5 31.9 10.1 92.5 5.2 2.3
10-14 52.7 31.4 9.0 93.1 4.5 2.4
15-19 42.3 36.9 10.3 89 .4 7.3 3.3
Ecst North Central
1-4 18.2 36.4 16.9 71.4 17.7 10.9
5-9 36.2 41.9 11.4 89 .5 7 .7 2.8
10-14 35.8 44.9 10.0 90.7 7.6 1.7
15-19 31.8 45.0 9.5 86.3 10.0 3.8
We.st North Central
1-4 19.3 35.1 15.5 69.9 17.9 12.1
5-9 36.4 38.3 11.1 85.8 10.3 3 .9
10-14 38.8 43.0 10.0 91.8 5.6 2.6
15-19 35.4 43.2 11.1 89.7 6.7 3.6
South Atlantic
1-4 25 .3 18.7 27 .8 71.8 17.9 10.3
5-9 52.2 22.5 15.0 89.7 7.7 2.5
10-14 56.0 23.2 14.1 93.4 5.1 1 .5
15-19 49.8 25.7 13.0 88.5 7 .3 4.1
Egist South Central
1-4 33.1 11 .7 31.4 76.1 11.6 12.2
5-9 59.0 13.2 15 .5 87.7 5.7 6.7
10-14 64.8 11.2 16.6 92.6 3 .7 3.7
15-19 59.5 13.7 17.2 90.4 5.4 4.2
Table 5. cont . Poliovaccine Status - United States, 1965. Ages Under 20 Years 
Inactivated Poliovaccine (1FV) and Oral Poliovaccine (OPV) 
Percent with Doses as Specified 
Geographic Divisions
Age
3 or more XPV 
and 
3 OPV
3 or more IPV 
and
Less than 3 OPV





1.2 OPV +1,2 IPV
1.2 OPV + 0 IPV 





1-4 24.5 13.4 28.4 66.3 17.4 16.3
5-9 51.2 13.1 22.3 86.6 9.9 3.5
10-14 54.4 13.9 21 .5 89.7 8.1 2.2
15-19 50.6 15.1 21.2 86.9 8.8 4.3
Mountain
1-4 25.3 18.8 31.9 76.0 17.2 6.8
5-9 49.1 16.0 24.1 89.2 5.8 5.1
10-14 59.5 13.1 20.9 93.5 5.3 1.3
15-19 56.6 13.7 21.7 92.0 6.6 1.4
Pacific
1-4 22.0 22.0 31.6 75.5 16.8 7.6
5-9 47.9 27.5 17.5 93 .0 5.6 1.4
10-14 46.5 30.1 15.9 92.4 5.7 1.9
15-19 43.8 30.8 13.7 88.2 7.8 3 .9
*Also includes persons with unknown immunization status and unknown number of doses .

Tables 6-10
Section B. Diphtheria-Pertussis-Tetanus Immunization Status
Ages 1-9 Years
Table 6. Diphtheria-Pertussis-Tetanus (DPT) Immunization Status -
United States, 1965. Ages 1-9 Years
Number of Injections______________ Percent with
Age Population 
(thousands) 0 1-2 3 >4
Unknown 0 3 >4No. Stat.
1 3 958 495 645 1 925 774 78 40 12.5 48.6 19.6
2 3 9 67 475 512 1 551 1 331 59 40 12.0 39.1 33.6
3 4 214 435 429 1 430 1 799 77 44 10.3 33 .9 42 .7
4 4 3 63 397 429 1 257 2 133 101 46 9 .1 28.8 48.9
1-4 16 502 1 802 2 015 6 163 6 037 315 170 10.9 37 .3 36.6
5-9 20 3 61 1 035 1 487 3 614 13 461 608 155 5.1 17.7 66.1
Table 7. Diphther ia-Pertussis-Tetanus (DPT) Immunization 
United States, 1965. Ages 1-9 Years 




Percent with no vaccine 10.9 8.6 23.2
Percent with 3 doses 37 .3 38.7 30.1
Percent with 4 or more 36.6 39.1 23.2
Percent with 3 or more 73 .9 77.8 53 .3
Ages 5-9
Percent with no vaccine 5.1 4.0 11.3
Percent with 3 doses 17.7 17.3 20.2
Percent with 4 or more 66.1 68.7 51.0
Percent with 3 or more 83.9 86.0 71.2
Table 8. Diphtheria-Pertussis-Tetanus (DPT) Immunization Status - 
United States, 1965. Ages 1-9 Years 
Standard Metropolitan Statistical Areas
Percent with Specified Number of Injections 




Remaining SMS Areas 7.5




Remaining SMS Areas 3.4
Areas Outside SMS Areas 7.7
Ages 1-4
36.1 37 .0 73.1
38.0 40.7 78.7
31.4 27.6 59.0




15.8 69 .0 84.8
17.6 59 .9 77.5
17.0 69.2 86.2
19.6 62.6 82.2
Table 9. Diphtheria-Pertussis-Tetanus Immunization Status - 
United States, 1965. Ages 1-9 Years 
Major Geographic Divisions
Percent with Specified Number of Injections
Age__ 0 1-2 3 >4 0 1-2 3 >4 0 1-2 3 £4
New Ehgland Middle Atlantic East North Central
1rH 7.1 8.0 46.9 35.9 6.8 14.5 36.3 39.6 10.8 13.1 39.9 33.9
5-9 3.6 6.0 20.0 67.8 4.7 9.3 19.4 63.0 4.4 7 .3 15.9 69 .3
West North Central South Atlantic East South Central
1-4 9 .8 11.5 45.7 32.4 13.2 10.2 34.0 39.0 16.7 11.7 30.7 34.7
5-9 5.3 8.0 21.5 63.6 4.6 5.4 18.1 66.8 9.8 6.6 18.4 59.5
West South Central Mountain Pacific
1-4 20.4 8.6 26.9 40.2 8.5 11.7 48.6 28.8 7.2 15.7 36.1 37.8
5-9 9.6 6.0 13.0 67.6 4.9 6.6 24.4 59.1 2.2 8.5 15.9 69.3
Table 10. Diphtheria-Pertussis-Tetanus Immunization Status - United States, 1965- 
Percent of Children, 1-4 Years, with Specified Number of DPT 




0 1-2 3 >4
White
1 3 301 10.5 17.2 51.1 21.2
2 3 341 10.1 12.6 41.3 36.0
3 3 530 8.6 11.2 34.6 45.5
4 3 700 8.2 10.8 29 .2 51.8
Nonwhite
1 657 28.6 23.7 36.4 11.3
2 626 28.8 24.1 27.0 20.1
3 683 25.5 16.0 30.3 28.3
4 663 21.3 19.5 26.5 32.7
Note: In this table children reported as having an unknown number of injections 
are included in the percentages computed for 1 dose; those reported with 
status unknown, in percentages computed for 0 doses.
Section C. Immunization Status, Infants Under 1 Year
Table 11











United States. Total 3 872 36.6 23.0 62.9
Geographic Divisions
New England 248 47.6 15.7 63.3
Middle Atlantic 633 32.5 29 .9 65 .9
East North Central 794 30.2 27 .0 64.0
West North Central 280 30.0 28.2 63.9
South Atlantic 583 40.0 21.4 63 .8
East South Central 292 43 .2 19 .9 59.6
West South Central 394 31.2 16.2 48.5
Mounta in 182 46.2 17.6 69 .2
Pacific 466 43.6 20.0 66.3
Standard Metropolitan Statistical 
Area Classification
Central Cities, SMS Areas 1 146 37.9 23.3 61.1
Remaining SMS Areas 1 313 37.2 24.1 67 .7
Areas Outside SMS Areas 1 413 35 .0 21.9 59 .9
Note; In this table, infants reported as having an unknown number of doses or 
injections are considered to have 1 dose or injection.
Tables 12-13
Section D. Measles History and Measles Vaccine History,
by Age, for the United States









<1 3 872 2.0 5.9
1 3 958 8.3 15.2
2 3 9 67 15.7 24.6
3 4 214 23.6 31.3
4 4 363 29.9 36.2
5 4 151 37 .3 43 .9
6 3 973 46.7 50.5
7 4 019 55.4 58.2
8 4 157 64.3 63.5
9 4 061 67.9 63.9
10 3 994 70.2 64.1
Table 13. Percent of Persons
United
Reporting History of Measles Vaccine - 




Percent with History of 
Measles Vaccine
<1 3 872 6.5
1-4 16 501 33.2
5-9 20 3 61 19 .3
Tables 14-15
Section E. Standard Qrrors of the Estimated Percentages Computed
by the Bureau of the Census
The standard errors presented in Tables 14 and 15 provide an 
indication of the order of magnitude of the standard errors rather than 
precise values for any specific item. In order to derive standard errors 
that would be applicable to the wide variety of items and could be prepared 
at moderate cost, a number of approximations were required.
Table 14. Standard Error of the Estimated Percentage
A. Of Persons who Received Inactivated Poliovaccine; and 
of Persons who Received DPT Immunization
(68 Chances out of 100)
Estimated ________________________Base of Percentage (000)
Percentage 500 1.000 2.500 5.000 10.000 25.000 50.000 100.000
2 or 98 1.4 1 .0 .6 .4 .3 .2 .1 .1
5 or 95 2.1 1 .5 1.0 .7 .5 .3 .2 .2
10 or 90 3.0 2.1 1.3 .9 .7 .4 .3 .2
25 or 75 4.3 3 .0 1.9 1.4 1.0 .6 .4 .3
50 4.9 3.5 2.2 1.6 1.1 .7 .5 .3
B. Of Persons who Received Oral Poliovaccine;
Persons who Contracted Measles
(68 Chances out of 100)
and of
Estimated Base of Percentage (000)
Percentage 500 1.000 2,500 5,000 10.000 25,000 50.000 100,000
2 or 98 1.1 .8 .5 .3 .2 .2 .1 .1
5 or 95 1.7 1.2 .8 .5 .4 .2 .2 .1
10 or 90 2.3 1.6 1.0 .7 .5 .3 .2 .2
25 or 75 3.3 2.4 1.5 1.1 .7 .5 .3 .2
50 3 .9 2.7 1.7 1.2 .9 .5 .4 .3
C. Of Persons who Received Both Oral 
Inactivated Poliovaccine
and
(68 Chances out of 100)
Estimated Base of Percentage (000)
Percentage 250 500 1.000 2.500 5.000 10.000 25.000
2 or 98 1.7 1.2 .9 .6 .4 .3 .2
5 or 95 2.7 1.9 1,4 .9 .6 .4 .3
10 or 90 3.7 2.6 1 .9 1.2 .8 .6 .4
25 or 75 5.4 3.8 2.7 1.7 1.2 .9 .5
50 6.2 4.4 3.1 2.0 1.4 1.0 .6
Table 15. Standard Error of Level of Estimates of the Number of Persons
Immunized by Type of Immunization












250 35 27 31
500 49 39 44
1 000 69 54 61
2 500 109 85 92
5 000 152 120 120
10 000 210 165 140
25 000 305 245
50 000 3 60 305
Illustrations for Use of the Tables of Standard Errors 
(All numbers in thousands)
Table 1A shows that 24.3 percent (4006/16498) of children in the age group 1-4 
had received 3 or more injections of IPV and 3 doses of OPV. Using Table 14C, the 
standard error of 24.3 percent based on 16,498 children is found by taking 25 percent 
(in the first column) as approximately equal to 24.3 percent and interpolating between 
the standard errors, 0.9 and 0.5, given in the body of the table under bases 10,000 
and 25,000 respectively. Taking the interpolated value as 0.7 of a percentage point, 
the chances are 68 out of 100 that a complete census would have shown a result between 
23.6 and 25.0 percent of children age 1-4 with 3 or more injections of IPV and 3 doses 
of OPV; and 95 out of 100 that a census result would have been between 22.9 and 25.7 
percent.
The standard error of the number of 1-4 year old children, 4,006, who had received 
3 or more injections of IPV and 3 doses of OPV can be estimated from Table 15. Referring 
to this table, the number 4,006 falls between 2,500 and 5,000 in the column "Level of 
Estimate" so that the standard error of the estimate (fourth column, IPV and OPV) lies 
between 92 and 120. By linear interpolation, the standard error of the 4,006 children 
in the 1-4 year age group who were reported to have 3 injections of IPV and 3 doses of 
OPV is 109 (thousand). The chances are 68 out of 100 that a complete census would have 
differed by less than 109 thousand; and 95 out of 100 that the difference would have 
been less than 218 thousand.
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